Illuminare Biotechnologies has appointed Brian Longstreet as CEO, succeeding Walter Greenblatt, who will remain as Chairman and take on the role of Chief Financial Officer. Walter Greenblatt emphasized Longstreet’s extensive experience in driving strategic growth and navigating late-stage clinical development as crucial for the company’s transition into a mature, late-stage clinical entity. With 30 years in the pharmaceutical and biotechnology sectors, Longstreet aims to accelerate clinical timelines, expand the pipeline, and establish industry partnerships to move toward product commercialization.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.contractpharma.com/breaking-news/illuminare-biotechnologies-names-brian-longstreet-as-ceo/
